Page 180 - Binder2

Localized, Modular Production

Traditional biologic manufacturing is centralized by
necessity. The costs, regulations, and complexity make it
impossible to replicate in multiple regions. This leads to
long supply chains, bottlenecks, and a production
ecosystem vulnerable to geopolitical disruption or facility
shutdown.

Plants break that dependency.

Because the platform doesn’t rely on expensive
infrastructure, it can be produced almost anywhere:

• In university greenhouses
• On regional farms
• In containerized vertical grow units near urban
clinics
• Even on-site at major hospitals or health centers

This enables:

• Near-patient manufacturing
• Faster response to local outbreaks or disease
clusters
• Reduced transportation time and cost
• More equitable access across regions

In essence, this is distributed biologic manufacturing—a
model where drugs are made close to where they’re
needed, rather than shipped from centralized factories
thousands of miles away.

That’s not just efficiency - It’s resilience.

178